BJWTY yields 6.37% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 10
Combined, BJWTY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BJWTY + JNJ for your $10,000?
Beijing Enterprises Water Group Limited, together with its subsidiaries, provides water treatment services. The company operates through Sewage and Reclaimed Water Treatment and Construction Services, Water Distribution Services, and Technical and Consultancy Services segments. It constructs sewage and reclaimed water treatment plants, and seawater desalination plants, as well as provides construction services for comprehensive renovation projects in the People's Republic of China, Malaysia, Australia, New Zealand, and the Republic of Botswana. The company also offers sewage and reclaimed water treatment services in Mainland China, the Republic of Singapore, the Portuguese Republic, Australia, and New Zealand; and distributes and sells piped water in Mainland China, the Portuguese Republic, and Australia. In addition, it provides technical and consultancy services; and sells machineries related to sewage treatment and construction services for comprehensive renovation projects in Mainland China and Australia. Further, the company is involved in the licensing of technical know-how related to sewage treatment. Beijing Enterprises Water Group Limited is headquartered in Wan Chai, Hong Kong.
Full BJWTY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.